Oncology
David Scheinberg, MD
Vincent Astor Chair and Chairman, Molecular Pharmacology Program, Sloan Kettering Institute; Professor of Medicine, Weill Cornell Medicine
David A. Scheinberg, MD, PhD, is a distinguished physician-scientist at Memorial Sloan Kettering Cancer Center (MSK) in New York, NY, specializing in the care of patients with leukemia, particularly acute leukemia and promyelocytic leukemia. As a hematologist-oncologist, he treats hematologic malignancies using advanced immunotherapeutic approaches developed in his laboratory. His research focuses on novel targeted therapies, including the first humanized monoclonal antibodies for acute leukemia
40+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (American Board of Internal Medicine)
- Internal Medicine (American Board of Internal Medicine)
Education & Training
- The Johns Hopkins School of Medicine — MD, PhD, 1983
- Memorial Sloan Kettering Cancer Center — Fellowship, Hematology and Medical Oncology, 1985-1987
- New York Presbyterian Hospital (Cornell Campus) — Residency, Internal Medicine, 1983-1985
Peer Recognition
- The American Society for Clinical Investigation — Elected Member
2001
Recognition & Leadership
Awards & Honors
- Doris Duke Distinguished Clinical Science Professorship
- Lucille P. Markey Scholarship
- Leukemia and Lymphoma Society Translational Investigator Awards
- CapCure Awards
- Emil J. Freireich Award
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Memorial Sloan Kettering Cancer Center
Languages
English
Experience
40+ years in practice